Drug compounding for veterinary patients
- PMID: 16353910
 - PMCID: PMC2750966
 - DOI: 10.1208/aapsj070229
 
Drug compounding for veterinary patients
Abstract
Drugs have been compounded for veterinary practice for many years because it has been necessary in the course of routine practice. However, regulations and compliance policy guidelines (CPGs) should be recognized. A new CPG issued in July 2003 listed the current Food and Drug Administration (FDA) limitations on compounding for veterinary medicine. To summarize the guideline: drugs must not be compounded from bulk substances, and the compounding must not constitute manufacture of a new animal drug. Drug compounding on a case-by-case basis is allowed under the CPG. However, veterinarians and pharmacists must be aware of potential incompatibilities and practices that may interfere with the drug's stability, purity, and/or potency.
References
- 
    
- The United States Pharmacopeia and the National Formulary, USP 28, NF 23. Rockville, MD: United States Pharmacopeial Convention, Inc; 2005. Good compounding practices; pp. 2620–2457.
 
 - 
    
- FDA-CVM FDA/CVM's Compliance policy guide on compounding of drugs. J. Am Vet Med Assoc. 1996;209:2025–2029. - PubMed
 
 - 
    
- Symposium on Compounding in Veterinary Medicine.J Am Vet Med Assoc. 1993;205:189–303. - PubMed
 
 - 
    
- FDA-CVM. Food and Drug Administration Web site. Compounding of Drugs for Use in Animals. Compliance Policy Guide: Compliance Policy Guidance for FDA Staff and Industry. Ch 6, sub ch 600, §608.400. Available at: http://www.fda.gov/cvm/index/updates/compound.htm. Accessed July 2003.
 
 - 
    
- JAVMA Animal drugs seized. J Am Vet Med Assoc. 1999;214:21–21.
 
 
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
